Evidence map›Paper›PMID 33519434›Full record

ArticleFrontiers in pharmacology2020

Effects of

Yu Wang, Jiaping Xu, Jiehong Yang, Ling Zhang, Yuanjiang Pan, Liping Dou, Peng Zhou, Yizhou Xu, Chang Li, Yu He and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Yu WangInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Jiaping XuInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Jiehong YangSchool of Basic Medicine and Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
Ling ZhangInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Yuanjiang PanDepartment of Chemistry, Zhejiang University, Hangzhou, China.
Liping DouDepartment of Cardiology, Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Peng ZhouInstitute of Brain and Heart CO Treatment, Zhejiang Chinese Medical University, Hangzhou, China.
Yizhou XuDepartment of Cardiology, Hangzhou First People's Hospital, Hangzhou, China.
Chang LiInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Yu HeSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
Huifen ZhouInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Li YuInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Jingwen ChenDepartment of Cardiology, Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Shuwei HuangDepartment of Cardiology, Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Wei FuDepartment of Cardiac-Cerebral Diseases, Yinchuan Cardiac-Cerebral Treatment Internet Hospital, Yinchuan, China.
Haitong WanInstitute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, China.
Zhejiang Chinese Medical University · CNHangzhou First People's Hospital · CNYinchuan First People's Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic heart failure (CHF) is a common cardiovascular disease with high mortality and a poor prognosis, which places heavy burdens upon society and families. Traditional Chinese medicine (TCM) has been used extensively as complementary treatment for CHF.

Indexed as

clinical trialcomplementary medicineGuanxinshutong (GXST)heart failuretraditional Chinese medicine (TCM)

Identifiers

PMID33519434
PMCPMC7840487
OpenAlexW3118695265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.